Henry Lynch Award Lecture
This lecture is named in honour of Henry T. Lynch, an American physician noted for his discovery of familial susceptibility to different kinds of cancer, including pancreatic cancer. In 1984 he established the Hereditary Cancer Prevention Clinic at Creighton University in Omaha and the hereditary nonpolyposis colorectal cancer syndrome carries his name. The Henry T. Lynch award is the highest honour presented during the International Symposia on Inherited Diseases of the Pancreas.
The Henry Lynch Award lecture (June 13th, 9:10 h) will be given by its 2018 recipient John P. Neoptolemos, a British surgeon who currently serves as Professor of Surgery at the University of Heidelberg. Professor Neoptolemos is the initiator and cofounder of the European Registry of Hereditary Pancreatic Diseases (EUROPAC) and of the European Study Group for Pancreatic Cancer (ESPAC). His contributions to the understanding of inherited forms of pancreatic disorders as well as his innovations in adjuvant pancreatic cancer therapy are internationally outstanding and have changed many patients’ lives.
Rudi Ammann Memorial State of the Art Lecture
This lecture is named in honour of Rudolf W. Ammann (1926-2015), a Swiss gastroenterologist and emeritus Professor at the University of Zurich. His research focused on methods for detecting pancreatic enzyme insufficiency, he was among the first to discover a connection between chronic pancreatitis and pancreatic cancer and his long-term study on the natural history of chronic pancreatitis, involving 245 patients over 20 years, are a citation classics. Rudi Ammann was EPC president in 1978 and recipient of the Life Time Achievement Award of the European Pancreatic Club.
The Rudi Ammann Memorial State of the Art Lecture (June 14th, 10:30 h) will be given by Philippe Levy, a French gastroenterologist, pancreatic-disease-unit director at Hôpital Beaujon and a professor in Paris. His clinical work on the natural history of, and mortality associated with, pancreatic cystic tumours and pseudocysts, the classification of recurrent acute and chronic pancreatitis in epidemiology and guidelines, and his contributions to autoimmune and hereditary pancreatitis set international standards. Professor Levy with be the recipient of the Life Time Achievement Award of the European Pancreatic Club in 2018.
The Harald Goebell Memorial State of the Art Lecture
This lecture is named in honour of Harald Goebell (1932 – 2017), a German gastroenterologist and emeritus professor at the University of Essen. A focus of Harald Goebell’s research was the interplay between intestinal and pancreatic function, long since continued by his mentees Peter Layer and Manfred Singer. In 1979 he completed the first randomized controlled clinical trial for the treatment of pancreatitis (salmon-derived calcitonin). Harald Goebell was EPC president in 1982.
The Harald Goebell Memorial State of the Art Lecture (June 15th, 11:00 h) will be given by Hein Gooszen, a Dutch surgeon and professor emeritus at St. Radboud University in Nijmegen. He was instrumental in the foundation and funding of the Pancreatitis Werkgroep Nederland (the Dutch Pancreatitis Study Group) and largely responsible for its transparent grassroots governance, the motivation of its members, its international excellence and the mentoring of many young physician/surgeon scientist within its PhD program. Most of the recent advances in the treatment of severe acute pancreatitis are based on studies from the Dutch Pancreatitis Study Group.
The Henri Sarles Memorial State of the Art Lecture
This lecture is named after Henri Sarles (1922 –2017), a French physician and emeritus professor at the Université de Marseille, who was one of the founding fathers of Pancreatology in Europe and of the European Pancreatic Club. He was a pioneer in the exploration of the pathogenesis of chronic pancreatitis, the mechanism involved in the formation of pancreatic stones and calcifications and the discovery of a possible autoimmune pathology. Henri Sarles is the only person who served twice as EPC president: in 1967 and 1987.
The Henri Sarles Memorial State of the Art Lecture (June 15th, 15:40 h) will be given by Ashok K. Saluja an American biochemist and professor at the University of Miami. He belongs to an elite group of scientist whose achievements are equally split between work on pancreatitis and pancreatic cancer. In the former area his group has elucidated the pathophysiology of pancreatitis, specifically the disease-driving mechanisms related to intrapancreatic protease activation. In the latter field he has discovered one of the most promising treatment targets for pancreatic cancer, that of heat-shock-protein 70 inhibition, which is currently being investigated in phase three clinical trials.